D
Moderna, Inc. MRNA
NASDAQ
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings MRNA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating D
Reward Index Weak
Risk Index Weak
Risk Grade D
Reward Grade D+
Rating Factors MRNA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Fair
Solvency Index Excellent
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation MRNA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 1.13
Price History MRNA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 3.00%
30-Day Total Return 21.91%
60-Day Total Return 5.79%
90-Day Total Return 51.77%
Year to Date Total Return -5.28%
1-Year Total Return -28.68%
2-Year Total Return -40.38%
3-Year Total Return -21.95%
5-Year Total Return 449.28%
52-Week High % Change -35.41%
52-Week Low % Change 68.55%
Price MRNA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $163.24
52-Week Low Price $62.55
52-Week Low Price (Date) Nov 02, 2023
52-Week High Price (Date) Apr 14, 2023
Valuation MRNA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 40.37B
Enterprise Value 28.33B
Price/Earnings (TTM) --
Earnings Per Share (TTM) -12.42
Earnings Per Share Growth -162.14%
Price/Earnings To Growth --
Price/Sales (TTM) 6.08
Price/Book (Q) 2.91
Enterprise Value/Revenue (TTM) 4.14
Price $106.56
Enterprise Value/EBITDA (TTM) -7.83
Enterprise Value/EBIT -6.68
Market Cap Category Large Cap
Dividends and Shares MRNA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 395.00M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info MRNA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 617 714 6500
Address 200 Technology Square Cambridge, MA 02139
Website www.modernatx.com
Country United States
Year Founded 2010
Profitability MRNA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -61.90%
Profit Margin -68.83%
Management Effectiveness MRNA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -11.97%
Return on Equity --
Income Statement MRNA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 6.67B
Total Revenue (TTM) 6.85B
Revenue Per Share $17.34
Gross Profit (TTM) -2.69B
EBITDA (TTM) -3.62B
EBIT (TTM) -4.24B
Net Income (TTM) -4.71B
Net Income Avl. to Common (TTM) -4.71B
Total Revenue Growth (Q YOY) -44.71%
Earnings Growth (Q YOY) -85.19%
EPS Diluted (TTM) -12.42
EPS Diluted Growth (Q YOY) -85.11%
Balance Sheet MRNA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 8.60B
Cash Per Share (Q) $21.78
Total Current Assets (Q) 10.33B
Total Preferred Equity (Q) --
Total Equity (Q) 13.85B
Current Ratio (Q) 3.425
Book Value Per Share (Q) $36.27
Total Assets (Q) 18.43B
Total Current Liabilities (Q) 3.02B
Total Debt (Q) 1.24B
Total Liabilities (Q) 4.57B
Total Common Equity (Q) 13.85B
Cash Flow MRNA - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) 4.21B
Cash from Financing (TTM) -1.38B
Net Change in Cash (TTM) -289.00M
Levered Free Cash Flow (TTM) -2.38B
Cash from Operations (TTM) -3.12B
Weiss Ratings